NCT05182398

Brief Summary

Balance disorder is common in people with MS. As the disease worsens, it is associated with impaired balance, difficulty walking, decreased mobility, and an increased risk of falling. Given the prevalence and clinical significance of balance dysfunction in individuals with MS, the assessment of balance has become an important focus in MS clinical practice and research. The Four Square Step Test is a standard clinical measure used to assess dynamic standing balance. It is a timed test in which the individual is instructed to step rapidly forward, backward, and to the right and left over a low obstacle (a cane). The test assesses the ability to quickly change direction of movement and is a timed test involving the use of assistive devices. In the modified four-square stepping test, the floor is divided into four equal squares with tape instead of a cane. Performing the test with tape, instead of patients at risk of being stuck with a cane, will ensure its applicability to a wider patient population. The aim of the study is to examine the validity and reliability of the modified four-frame stepping test in MS patients.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started May 2022

Shorter than P25 for all trials

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 15, 2021

Completed
26 days until next milestone

First Posted

Study publicly available on registry

January 10, 2022

Completed
4 months until next milestone

Study Start

First participant enrolled

May 15, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 15, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 15, 2022

Completed
Last Updated

March 10, 2025

Status Verified

March 1, 2025

Enrollment Period

2 months

First QC Date

December 15, 2021

Last Update Submit

March 6, 2025

Conditions

Keywords

FallModified Four Square Step TestMultiple sclerosisBalance

Outcome Measures

Primary Outcomes (2)

  • Modified Four Square Step Test

    The square drawn on the floor is divided by tape into 4 equal parts. The number 1 is written in the lower right corner, and the number 4 is written clockwise. With the start command, individuals are asked to step on the numbers in order. First of all, he is asked to take a step forward (to the number 1 and 2), then to the left (to the number 3), then to the back (to the number 4). Then he is asked to take steps from 4 to 1 again. Time is saved

    First day

  • Modified Four Square Step Test

    The square drawn on the floor is divided by tape into 4 equal parts. The number 1 is written in the lower right corner, and the number 4 is written clockwise. With the start command, individuals are asked to step on the numbers in order. First of all, he is asked to take a step forward (to the number 1 and 2), then to the left (to the number 3), then to the back (to the number 4). Then he is asked to take steps from 4 to 1 again. Time is saved

    second day

Secondary Outcomes (3)

  • Berg Balance scale

    First day

  • Dynamic Gait Index

    First day

  • Activity-Specific Balance Confidence Scale

    First day

Study Arms (1)

Multiple sclerosis patient

First day, first evaluator will perform all tests, and second day, second evaluator will perform Modified Four Square Step Test.

Other: Assesment

Interventions

Modified Four Square Step Test, Berg Balance Scale, Dynamic Gait Index ,Activity-Specific Balance Confidence Scale

Multiple sclerosis patient

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Multiple Sclerosis Patients

You may qualify if:

  • Having an EDSS score of 4 and below,
  • Being between the ages of 18-65
  • Willingness to participate in the study

You may not qualify if:

  • Being pregnant or within the first 3 months after giving birth,
  • Receiving corticosteroid therapy in the last 1 month,
  • Using drugs that will affect walking in the last 1 month

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Multiple Sclerosis

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Zekiye İpek Katırcı Kırmacı

    Kahramanmaras Sutcu Imam University

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Asst. Prof.

Study Record Dates

First Submitted

December 15, 2021

First Posted

January 10, 2022

Study Start

May 15, 2022

Primary Completion

July 15, 2022

Study Completion

August 15, 2022

Last Updated

March 10, 2025

Record last verified: 2025-03